WAGNER CHARLES F JR (EVP and CFO) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2026ACC: 0000875320-26-000100
Officer· EVP and CFO
Since Apr 2019
+5.07K
Net shares
Net buyer
$1.11M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
7.37K acquired · 2.29K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.37K
Price / share
—
Trade value
—
% of position
16.8%
2/17/2026
43.72K→51.08K
Common Stock
Direct
Shares
−2.29K
Price / share
$483.75
Trade value
$1.11M
% of position
4.5%
2/17/2026
51.08K→48.79K
Total
Net shares
+5.07K
Net value
-$1.11M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +7.37K | — | — | 16.8% | 43.72K | 51.08K |
| Common Stock Direct | 2/17/2026 | F · Tax Withholding | −2.29K | $483.75 | $1.11M | 4.5% | 51.08K | 48.79K |
| Total | +5.07K | -$1.11M | ||||||
Derivative Transactions0
No derivative transactions reported